Skip to content
Trial Eligibility
Menu

Opioid Dispensing Device for Post-Operative Pain in Cancer Patients

NCT05585788

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

This research study will evaluate the use of, and participants experience with, a new device called Addinex that safely stores and dispenses opioid medication. The purpose of this study is to evaluate the use of the Addinex device in cancer patients undergoing cancer-related surgery that require pain control with opioids after the surgery. Participants will be asked to answer questions about their medical history and background, fill out questionnaires, use a mobile application associated with the device, and undergo a phone interview one month after stopping use of the device.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Opioid Use
  • Breast Cancer

Eligibility basics and study details

Study type
Interventional
Phase
Not applicable
Ages
18 to 99 years
Sex
All
Healthy volunteers
Not accepted
Sponsor
Columbia University
Last updated on ClinicalTrials.gov
July 10, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

New York · 1

  • Columbia University Medical Center · New York, NY

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.